Cargando…
Downstream bioprocessing of human pluripotent stem cell‐derived therapeutics
With the advancement in lineage‐specific differentiation from human pluripotent stem cells (hPSCs), downstream cell separation has now become a critical step to produce hPSC‐derived products. Since differentiation procedures usually result in a heterogeneous cell population, cell separation needs to...
Autores principales: | Sart, Sebastien, Liu, Chang, Zeng, Eric Z., Xu, Chunhui, Li, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635003/ https://www.ncbi.nlm.nih.gov/pubmed/36348655 http://dx.doi.org/10.1002/elsc.202100042 |
Ejemplares similares
-
Bioprocessing of Cryopreservation for Large-Scale Banking of Human Pluripotent Stem Cells
por: Li, Yan, et al.
Publicado: (2012) -
A Scalable and Efficient Bioprocess for Manufacturing Human Pluripotent Stem Cell-Derived Endothelial Cells
por: Lin, Haishuang, et al.
Publicado: (2018) -
Bioprocess and downstream optimization of recombinant human growth hormone in Pichia pastoris
por: Azadi, Saeed, et al.
Publicado: (2018) -
Bioprocessing of Mesenchymal Stem Cells and Their Derivatives: Toward Cell-Free Therapeutics
por: Phelps, Jolene, et al.
Publicado: (2018) -
High density bioprocessing of human pluripotent stem cells by metabolic control and in silico modeling
por: Manstein, Felix, et al.
Publicado: (2021)